(Circulation. 2001;104:2809.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Medical Genetics and Pediatric Cardiology, Bambino Gesù Hospital, Rome (M.C.D., A.T., A.G.); the Department of Pathology, Baylor College of Medicine and Texas Childrens Hospital, Houston (B.C.); the Department of Pediatric Cardiology, Monaldi Hospital, Napoli, Italy (R.C., G.P.); the Department of Pediatric Cardiology, G. Gaslini Hospital, Genova, Italy (M.M.); the Department of Pediatric Cardiology, Regina Margherita Hospital, Torino, Italy (E.B.); the Department of Medical Genetics, La Sapienza University and Mendel-CSS Institute, Rome, Italy (B.D.); and the Division of Pediatric Cardiology, Department of Pediatrics, La Sapienza University, Rome, Italy (B.M.).
Correspondence to B. Marino, Cardiologia Pediatrica, Istituto di Pediatria, Università La Sapienza, Viale Regina Elena 324, 00161, Roma, Italia. E-mail bruno.marino{at}uniroma1.it
| Abstract |
|---|
|
|
|---|
Methods and Results From January 1997 through December 2000, 370 patients with nonsyndromic, complete TGA were consecutively evaluated and enrolled in the study. The occurrence of cardiac and noncardiac anomalies among relatives of the probands was investigated. Relatives with congenital heart disease were found in 37 of 370 families (10%), including 5 of 37 families (13.5%) with more than one affected relative. TGA itself was the most common precurrent malformation: complete TGA occurred in 6 families and congenitally corrected TGA occurred in 5 families. Precurrence risks for congenital heart disease were calculated at 1.8% (8 of 436) for siblings, 0.5% (4 of 740) for parents, 0.5% (16 of 3261) for first cousins, 0.2% (4 of 2101) for uncles/aunts, and 0.06% (1 of 1480) for grandparents.
Conclusions The present study shows that TGA is not always sporadic in families. Precurrence of concordant cardiac defects within affected family members supports monogenic or oligogenic inheritance of TGA in certain kindreds. Moreover, the occurrence of complete TGA and congenitally corrected TGA among first-degree relatives in several different families strongly suggests an underlying pathogenetic link between these 2 malformations that has been previously unrecognized.
Key Words: heart defects, congenital transposition of great vessels genetics
| Introduction |
|---|
|
|
|---|
The genetic contribution to the pathogenesis of TGA is not considered to be strong given that very few familial cases have been described6,7 and that genetic syndromes or extracardiac malformations are uncommonly associated with TGA.1,8 Currently, the mean precurrence risk for CHD among siblings of patients affected with any type of TGA is considered to be 1.4%,7,917 and a recent large population study failed to identify any familial precurrence among 20 offspring of adult patients with TGA.16
Information about precurrence risks among different subgroups of TGA have been provided in only one study,17 which reported that patients with complete TGA (ie, situs solitus, D-loop ventricle, and TGA with or without a ventricular septal defect [VSD]) have the lowest precurrence rate of CHD among siblings (0.27%), whereas a precurrence risk of 2% has been calculated for siblings of patients with complex TGA (with or without a single ventricle, tricuspid atresia, or double outlet right ventricle) or with TGA with the asplenia syndrome/right isomerism form of heterotaxy. Correspondingly, the results of the Baltimore-Washington Infant Study8 showed that complete TGA also has a lower percentage of associated extracardiac defects in comparison with complex TGA.
Anecdotal clinical experience suggested that the occurrence of familial CHD among index cases of TGA might be higher than previously reported, particularly among the subgroup of patients with complete TGA. This study was designed specifically to investigate this hypothesis and to determine whether any particular CHD occurred more commonly than others among relatives of index cases.
Considering that most previous familial studies have involved a relatively small number of patients and evaluated all types of TGA as a single group, we performed a prospective investigation of familial precurrence of CHD in families of children with complete TGA evaluated in 5 Italian departments of pediatric cardiology over 4 years. The study was designed to verify if the familial analysis of a large series of patients could help in the identification of pedigrees at high risk for CHD and to study the types of CHD occurring in relatives of patients with complete TGA.
| Methods |
|---|
|
|
|---|
Clinical and phenotypical evaluations were performed in all patients by a geneticist to detect extracardiac anomalies. The definition of nonsyndromic was based on an examination at the time of the enrollment in the study. Standard karyotype on peripheral lymphocytes and fluorescent in situ hybridization with Sc11.1 probe for 22q11.2 microdeletion were performed in all cases. Patients with major extracardiac malformations and/or with facial dysmorphisms in the setting of chromosome anomalies, mendelian syndromes, or associations (28 patients) and one patient with a 22q11.2 microdeletion were excluded.
Information about family history was obtained by an interview with the parents of the index cases. The precurrence of cardiac and noncardiac congenital anomalies in relatives of the probands was investigated. Family pedigrees were constructed to include siblings, parents, grandparents, aunts/uncles, and first cousins. Information about more distant relatives was volunteered by some families. The study was approved by our ethics committee. All living first-degree relatives underwent clinical and electrocardiographic examination. In families in which CHD occurred in more than one member, a complete echocardiographic study was performed on all living first- and second-degree relatives.
| Results |
|---|
|
|
|---|
2 analysis (with P<0.05 accepted as significant), is statistically significant (P=0.01).
One or more relatives with CHD were found in 37 of the 370 families (10%). In particular, familial precurrence of CHD was detected in 22 of 246 families (8.9%) of probands with TGA and IVS and in 15 of 124 families (12.1%) of probands with TGA and VSD (P=0.441). The affected relatives had complete TGA in 6 families (Figure 1) and congenitally corrected TGA (situs solitus, L-loop ventricle with discordant atrioventricular connections, and TGA with discordant ventriculoarterial connections) in 5 families (Figure 2). Different types of CHD were also found among relatives of 2 of the families included in Figure 1. In the remaining 26 families, the affected relatives had CHDs different from TGA (Table 1). Some pedigrees with familial aggregation of TGA included in the present study were also previously reported.18,19 Precurrence risks for CHD among relatives in our series of patients with TGA are shown in Table 2. Considering the occurrence of CHD in first-degree relatives of our probands, the heritability of TGA can be estimated as
10% .
|
|
|
|
Noncardiac anomalies in relatives of the probands were identified in 36 families. The type of noncardiac anomaly is shown in Table 3. The risk rates for noncardiac anomalies in relatives of our probands were 0.7% (3 of 436) for siblings, 0.5% (4 of 740) for parents, 0.8% (26 of 3261) for first cousins, and 0.3% (7 of 2101) for uncles/aunts.
|
Consanguinity was identified in the parents of 5 probands (second cousins in 4 cases and first cousins in one). Eight probands with TGA (6 with TGA and IVS and 2 with TGA and VSD, P=0.89) had an unaffected twin sibling (dizygotic in 5 cases, monozygotic in 3). The ethnicity of the families was Italian in 369 of the 370 families; the ethnicity of the remaining family (pedigree 2 in Figure 1) was Slavic gypsy.
| Discussion |
|---|
|
|
|---|
According to previous literature reports, the mean precurrence rate in siblings of patients with TGA is considered to be 1.4%,7,917 which is just lower than that in our results. In this regard, it is important to consider that most of the studies investigating familial TGA are referring to all types of TGA as a single group. The only exception is the article by Becker et al,17 which showed that the study group of complete TGA (168 patients) had a precurrence rate of only 0.27%. The recent population study published by Burn et al,16 which investigated vertical transmission of TGA, found no cases of CHD among 20 offspring of 104 probands with TGA. In the same study, the precurrence of CHD in siblings of patients with TGA was 0.97% (one case among 103 siblings).
The variety of recurrence risk rates found among different studies may reflect different genetic and geographic backgrounds in populations. The finding of more families with precurrent TGA than previously expected could mean that a study of large numbers of patients may identify pedigrees at high risk for CHD. A combination of chance, decreased penetrance, and nondominant transmission may account for the absence of vertical transmission of CHD found in the study performed by Burn et al.16 Ascertainment bias may also affect the study results, because different anatomic types of TGA allowing survival to adulthood could have a possible different genetic impact in comparison with more severe TGA.
The rate of consanguinity in our series is 1.4% (5 of 370 families). Only few data are available from the literature, but first-cousin matings among parents of patients with TGA have been occasionally reported.20
The higher proportion of male patients affected by TGA reported in previous series1,21,22 was confirmed in our experience. In addition, a statistically significant male preponderance in patients with TGA and IVS in comparison with those with TGA and VSD was also found in our study, similar to the observations reported in the Baltimore-Washington Infant Study.21 The segregation of an X-linked gene could be suspected in families with precurrent TGA in males (Figures 1 and 2), but this type of transmission can be excluded in most of our families because of apparent male-to-male segregation of a putative disease gene (Figures 1 and 2).
Kindreds with familial TGA show that both TGA with VSD and TGA with IVS can occur in the same family. No significant difference was found in precurrence risk rates in families of patients with TGA and IVS in comparison with those of patients with TGA and VSD. Discordant CHDs precurring more often in our pedigrees include tetralogy of Fallot and VSD (Table 1); a multifactorial mode of inheritance of predisposition to familial CHD can be hypothesized in these cases.
Some patterns of familial precurrence observed in our study suggest that the recent pathogenetic classification of CHD is not completely adequate to account for all cases of TGA. In fact, according to the pathogenetic classification proposed by Clark,23,24 complete TGA is grouped among conotruncal heart defects due to abnormalities of ectomesenchymal tissue migration, which are frequently associated with chromosomal deletion 22q11.2 in the setting of DiGeorge/velocardiofacial syndrome. Actually, only a few cases of TGA and deletion 22q11.2 have been reported,2527 suggesting that in only a small percentage of cases can TGA be definitively explained on the basis of a defect in neural crest cell migration. An interesting observation in our series is the occurrence of tetralogy of Fallot related to deletion 22q11.2 in a sister of a male proband with TGA without chromosomal abnormalities (Table 1). The occurrence of CHD in siblings with discordant karyotypes supports the existence of additional genetic predisposing factors, which could play a role in the pathogenesis of familial aggregation of CHDs.28
Ferencz et al,21 however, classified TGA with the group of conotruncal anomalies, but separated this malformation from those with "normally related great arteries," ie, tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch. In fact, TGA seems to differ from the other types of conotruncal defects: it presents with a lower percentage of associated extracardiac anomalies,1,8 a lower risk of familial precurrence of CHD,6,7 and a lower prevalence of deletion 22q11.2.2527
According to general consent, congenitally corrected L-TGA is not included in the group of conotruncal defects, but is classified among the situs and looping abnormalities.21,23,24 The presence of congenitally corrected L-TGA in 5 first-degree relatives of our patients with TGA is quite surprising (Figure 2). Aggregation of complete TGA and L-TGA in the same family suggests a possible genetic and causative connection between the 2 defects. Considering the high prevalence of TGA in patients with heterotaxy29 and based on these cases of familial aggregation, the pathogenetic group of situs and loop abnormalities might include at least some cases of complete TGA.
In this regard, it is interesting to note that a relationship between complete TGA and laterality defects is corroborated by molecular studies investigating some new genes. In fact, mice trans-heterozygous for both SMAD2 and nodal mutations can have TGA, which is associated with right pulmonary isomerism in some cases.30 Mutations of the EGF-CFC gene, CRYPTIC, in humans have been found to be associated with heterotaxic phenotypes31 as well as with some cases of complete TGA.32
In addition, a mutation in the ZIC3 gene, an X-linked gene related to sporadic and familial situs abnormalities, has been detected in a family in which affected males have TGA and midline anomalies but no obvious left-right malformations.33 Familial segregation of both laterality defects and isolated TGA has been also recently observed in one family.34 All these data support the hypothesis that TGA could be included within the spectrum of laterality defects in some cases.
Data from animal studies support the suggestion that TGA and situs/looping abnormalities may be related pathogenetically. Although TGA is the most difficult cardiac malformation to reproduce experimentally, a consistent model of TGA was recently obtained by all-trans retinoic acid administration during mouse pregnancy.35,36 In this animal model, TGA could be found in the presence of both D- and L-loops of the ventricles (ie, complete TGA and congenitally corrected TGA),35 and treatment with retinoic acid in mouse embryos also could induce looping anomalies with right isomerism.37 Moreover, complete TGA (ie, with situs solitus and D-loop ventricle) can be present among heart defects of homozygous iv/iv mice presenting with a high prevalence of visceral heterotaxy and lateralization anomalies.38 Animal models, therefore, support a common pathogenetic mechanism involved in causing some cases of complete TGA along with congenitally corrected TGA and other laterality defects. Complete TGA could be considered a less severe manifestation than typically encountered.
Noncardiac heritable disorders in relatives of patients with complete TGA include a great variety of conditions. Previous observations from the literature report a preferential occurrence of heritable blood disorders in parents of children with TGA,1,39 and this association was also noted in one of the families from our series (Table 3). The rarity of TGA and of hemophilia in the population suggests that the co-occurrence of these diseases in a family could be causally related. Also, in our series (Table 3) as in previous epidemiological studies,1 congenital hypothyroidism was found in relatives of patients with TGA.
In the present study, some limitations concerning the methods of ascertainment of the cases can be pointed out. In fact, our study is not a population-based analysis, considering that our series consists of patients with TGA enrolled at time of hospital admission. In addition, the great majority of the patients were collected when seen for a postoperative appointment. This could constitute a bias in data evaluation, particularly considering that TGA has high preoperative and intraoperative mortality.20 An additional limitation could be due to the fact that imaging tests for CHD were performed routinely only in the first degree relatives of the probands, whereas the presence of CHD in more distant relatives was investigated by interview.
| Conclusions |
|---|
|
|
|---|
The complexity of these observations suggests a multigenic origin of TGA, probably with the involvement of multiple or even unrecognized causative and pathogenetic mechanisms. Large families with multiple members affected by CHD are fundamental for the identification of the genes related to the specific malformations using genetic techniques such as linkage analysis and positional cloning. The collection of pedigrees segregating the gene(s) of interest will provide an important aid for the delineation of the human gene map of CHDs.
Received June 14, 2001; revision received September 26, 2001; accepted September 26, 2001.
| References |
|---|
|
|
|---|
2. Fyler DC, Buckley LP, Hellenbrand WE, et al. Report of the New England Regional Infant Cardiac Program. Pediatrics. 1980; 65 (suppl): 375461.[Medline] [Order article via Infotrieve]
3. Samanek M. Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young. 2000; 10: 179185.[Medline] [Order article via Infotrieve]
4.
Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. Am J Epidemiol. 1985; 121: 3136.
5. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol. 1999; 20: 411417.[Medline] [Order article via Infotrieve]
6.
Nora JJ, Meyer TC. Familial nature of congenital heart diseases. Pediatrics. 1966; 37: 329334.
7. Nora JJ, Berg K, Nora AH. Cardiovascular Diseases: Genetics, Epidemiology and Prevention. New York: Oxford University Press; 1991.
8. Lurie IW, Kappetein AP, Loffredo CA, et al. Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore-Washington Infant Study (19811989). Am J Med Genet. 1995; 59: 7684.[Medline] [Order article via Infotrieve]
9.
Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circulation. 1968; 38: 604617.
10. Fuhrmann W. A family study in transposition of the great vessels and in tricuspid atresia. Humangenetik. 1968; 6: 148157.[Medline] [Order article via Infotrieve]
11. Anderson RC. Fetal and infant death, twinning and cardiac malformations of 2000 children with and without congenital heart disease. Am J Cardiol. 1976; 38: 218224.[Medline] [Order article via Infotrieve]
12. Sanchez-Cascos A. The recurrence risk in congenital heart disease. Eur J Cardiol. 1978; 7: 197210.[Medline] [Order article via Infotrieve]
13.
Nora JJ, Nora AH. The evolution of specific genetic and environmental counseling in congenital heart diseases. Circulation. 1978; 57: 205213.
14. Briard ML, Chauvet ML, Le Merrer M, et al. Etude épidémiologique et génétique de trois cardiopathies congénitales à révélation néonatale. Arch Fr Pediatr. 1984; 41: 313321.[Medline] [Order article via Infotrieve]
15. Nora JJ, Nora AH. Update on counseling the family with a first-degree relative with a congenital heart defect. Am J Med Genet. 1988; 29: 137142.[Medline] [Order article via Infotrieve]
16. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998; 351: 311316.[Medline] [Order article via Infotrieve]
17. Becker TA, Van Amber R, Moller JH, et al. Occurrence of cardiac malformations in relatives of children with transposition of the great arteries. Am J Med Genet. 1996; 66: 2832.[Medline] [Order article via Infotrieve]
18. Digilio MC, Marino B, Giannotti A, et al. Familial recurrence of transposition of the great arteries and intact ventricular septum. Am J Med Genet. 1997; 73: 9394.[Medline] [Order article via Infotrieve]
19. Digilio MC, Marino B, Banaudi E, et al. Familial recurrence of transposition of the great arteries. Lancet. 1998; 351: 1661.
20. Becker SM, Al Halees Z, Molina C, Paterson RM. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet. 2001; 99: 813.[Medline] [Order article via Infotrieve]
21. Ferencz C, Loffredo CA, Correa-Villasenor A, et al. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: the Baltimore-Washington Infant Study, 19811989. Armonk, NY: Futura Publishing Company; 1997.
22. Samanek M. Boy:girl ratio in children born with different forms of cardiac malformations: a population-based study. Pediatr Cardiol. 1994; 15: 5357.[Medline] [Order article via Infotrieve]
23. Clark EB. Mechanisms in the pathogenesis of congenital cardiac malformations.In: Pierpont ME, Moller JH, eds. Genetics of Cardiovascular Disease. Boston: Nijhoff; 1986: 311.
24. Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol. 1996; 20: 465472.[Medline] [Order article via Infotrieve]
25. Melchionda S, Digilio MC, Mingarelli R, et al. Transposition of the great arteries associated with deletion of chromosome 22q11.2. Am J Cardiol. 1995; 75: 9598.[Medline] [Order article via Infotrieve]
26. Mehraein Y, Wippermann CF, Michel-Behnke I, et al. Microdeletion 22q11.2 in complex cardiovascular malformations. Hum Genet. 1997; 99: 433442.[Medline] [Order article via Infotrieve]
27. Marble M, Morava E, Lopez R, et al. Report of a new patient with transposition of the great arteries with deletion of 22q11.2. Am J Med Genet. 1998; 78: 317318.[Medline] [Order article via Infotrieve]
28. Digilio MC, Marino B, Canepa SA, et al. Congenital heart defect in sibs with discordant karyotypes. Am J Med Genet. 1998; 80: 169172.[Medline] [Order article via Infotrieve]
29. Phoon CK, Neill CA. Asplenia syndrome: insight into embryology through the analysis of cardiac and extracardiac anomalies. Am J Cardiol. 1994; 73: 581587.[Medline] [Order article via Infotrieve]
30. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 1998; 393: 786790.[Medline] [Order article via Infotrieve]
31. Bamford RN, Roessler E, Burdine RD, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet. 2000; 26: 365369.[Medline] [Order article via Infotrieve]
32. Bamford RN, de la Cruz J, Roessler E, et al. Mutations in the EGF-CFC gene, CRYPTIC, cause human left-right axis abnormalities and transposition of the great arteries. Am J Hum Genet. 2000; 67 (suppl 2): 10.Abstract.
33. Mégarbané A, Salem N, Stephan E, et al. X-linked transposition of the great arteries and incomplete penetrance among males with nonsense mutation in ZIC3. Eur J Hum Genet. 2000; 8: 704708.[Medline] [Order article via Infotrieve]
34. Morelli SH, Young L, Reid B, Ruttenberg H, Bamshad MJ. Clinical analysis of families with heart, midline, and laterality defects. Am J Med Genet. 2001; 101: 388392.[Medline] [Order article via Infotrieve]
35. Pexieder T, Blanc O, Pelouch V, et al. Late fetal development of retinoic acid-induced transposition of great arteries: morphology, physiology, and biochemistry.In: Clark EB, Markwald RR, Takao A. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing; 1995: 297307.
36. Nakajima Y, Morishima M, Yasui H, et al. Molecular mechanisms of complete transposition of the great arteries produced by all-trans retinoic acid in mouse embryo.In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing; 1995: 315317.
37. Yasui H, Morishima M, Nakazawa M, et al. Anomalous looping, atrioventricular cushion dysplasia, and unilateral ventricular hypoplasia in the mouse embryo with right isomerism induced by retinoic acid. Anat Rec. 1998; 250: 210219.[Medline] [Order article via Infotrieve]
38.
Icardo JM, Sanchez de Vega MJ. Spectrum of heart malformations in mice with situs solitus, situs inversus, and associated visceral heterotaxy. Circulation. 1991; 84: 25472558.
39. Ferencz C, Boughmann JA, Neill CA, et al. Congenital cardiovascular malformations: questions on inheritance. J Am Coll Cardiol. 1989; 14: 756763.[Abstract]
This article has been cited by other articles:
![]() |
S. M. Zhivora Improving Detection of Transposition of the Great Arteries in Routine Obstetric Sonographic Screening Journal of Diagnostic Medical Sonography, September 1, 2008; 24(5): 279 - 283. [Abstract] [PDF] |
||||
![]() |
M. T.R. Roofthooft, K. A. Bergman, T. W. Waterbolk, T. Ebels, B. Bartelds, and R. M.F. Berger Persistent Pulmonary Hypertension of the Newborn With Transposition of the Great Arteries Ann. Thorac. Surg., April 1, 2007; 83(4): 1446 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, M. J. Kocica, and F. Torrent-Guasp The helical ventricular myocardial band of Torrent-Guasp: potential implications in congenital heart defects Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S61 - S68. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Drenthen, P. G. Pieper, M. Ploeg, A. A. Voors, J. W. Roos-Hesselink, B. J.M. Mulder, H. W. Vliegen, K. M. Sollie, T. Ebels, D. J. van Veldhuisen, et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries Eur. Heart J., December 1, 2005; 26(23): 2588 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Muncke, C. Jung, H. Rudiger, H. Ulmer, R. Roeth, A. Hubert, E. Goldmuntz, D. Driscoll, J. Goodship, K. Schon, et al. Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients With Congenital Heart Defect (Transposition of the Great Arteries) Circulation, December 9, 2003; 108(23): 2843 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marino and A. F. Corno Spiral pattern: universe, normal heart, and complex congenital defects J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1225 - 1226. [Full Text] [PDF] |
||||
![]() |
H. K. Gill, M. Splitt, G. K. Sharland, and J. M. Simpson Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography J. Am. Coll. Cardiol., September 3, 2003; 42(5): 923 - 929. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |